Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-02-09 @ 3:23 AM
Study NCT ID:
NCT04568434
Status:
COMPLETED
Last Update Posted:
2025-03-06
First Post:
2020-09-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization: